Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease
American Journal of Preventive Cardiology · 2026-10 · 102560
DOI: 10.1016/j.ajpc.2026.102560 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-10. Verfasst von Anthony J. Viera und 1 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Uncontrolled hypertension remains the single greatest contributor to cardiovascular disease morbidity and mortality worldwide. Even modest elevations, so-called “high-normal” BP levels, confer significant risk over the course of a lifetime. However, the current treatment paradigm remains rooted in a threshold-based strategy in which treatment is only initiated after BP exceeds predefined cut-points, leaving many who might benefit over the long term untreated. Shifting the paradigm towards earlier treatment and prevention of overt hypertension would require a target that is upstream, durable, and demonstrably safe for long-term use in lower-risk populations. In this review, we examine the concept that targeting angiotensinogen, the most upstream precursor in the renin–angiotensin–aldosterone system (RAAS), could contribute to an earlier, trajectory-focused strategy for preventing hypertension and cardiovascular disease. We review the rationale for targeting angiotensinogen, summarize the evidence for current agents in development, and propose a research agenda to determine whether this approach can safely delay or prevent incident hypertension in selected at-risk populations.
Zitieren
APA
Viera, A. J., & Pagidipati, N. J. (2026). Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease. American Journal of Preventive Cardiology, 102560. https://doi.org/10.1016/j.ajpc.2026.102560
Vancouver
Viera AJ, Pagidipati NJ. Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease. American Journal of Preventive Cardiology. 2026:102560. doi:10.1016/j.ajpc.2026.102560
BibTeX
@article{Viera2026,
author = {Viera, Anthony J. and Pagidipati, Neha J.},
title = {Targeting angiotensinogen for the upstream prevention of hypertension and cardiovascular disease},
journal = {American Journal of Preventive Cardiology},
year = {2026},
pages = {102560},
doi = {10.1016/j.ajpc.2026.102560}
}
EUVIMED